Comparison of Visfatin Levels Before and After Non-surgical Periodontal Therapy: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2025 Feb 19

PMID 39970162

Authors

Zahra Tajik

Hamid Mehrafarid

Mojtaba Bayani

Amir Almasi-Hashiani

Affiliations

Soon will be listed here.

Abstract

Periodontitis is an inflammatory disease and involves a severe inflammation of the periodontium. On the other hand, visfatin is known as one of the inflammatory markers and can probably preserve inflammation in immune cells. Therefore, the purpose of this systematic review and meta-analysis is to compare the mean visfatin level before and after non-surgical periodontal treatment (NSPT). In this systematic review and meta-analysis, to find relevant studies, PubMed, Web of Science and Scopus were searched. Google Scholar was used to review gray literature. Standardized mean difference (SMD) along with 95% confidence interval (95%CI) was calculated. To perform the meta-analysis, in cases where there was significant heterogeneity between the studies, the random-effects model was used, otherwise the fixed-effects model was used. Sixteen studies were included in the meta-analysis. The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. Following the NSPT, the mean visfatin level of GCF, serum and saliva decreases, and in longer follow up time, the level of visfatin decreases significantly. Also, the mean GCF level of diabetic patients decreased after NSPT. Therefore, visfatin level may be used as a diagnostic and therapeutic noninvasive biomarker in patients with periodontitis, which requires further studies.

References

Abolfazli N, Jabali S, Saleh Saber F, Babaloo Z, Shirmohammadi A . Effect of Non-surgical Periodontal Therapy on Serum and Salivary Concentrations of Visfatin in Patients with Chronic Periodontitis. J Dent Res Dent Clin Dent Prospects. 2015; 9(1):11-7. PMC: 4417487. DOI: 10.15171/joddd.2015.003. View

Bulcao C, Ferreira S, Giuffrida F, Ribeiro-Filho F . The new adipose tissue and adipocytokines. Curr Diabetes Rev. 2008; 2(1):19-28. DOI: 10.2174/157339906775473617. View

Mopidevi A, Penmetsa G, Dwarkanath C, Dubba K, Gadde P . Salivary visfatin concentrations in patients with chronic periodontitis: An analysis before and after periodontal therapy. Indian J Dent Res. 2020; 30(6):864-869. DOI: 10.4103/ijdr.IJDR_673_17. View

Sczepanik F, Grossi M, Casati M, Goldberg M, Glogauer M, Fine N . Periodontitis is an inflammatory disease of oxidative stress: We should treat it that way. Periodontol 2000. 2020; 84(1):45-68. DOI: 10.1111/prd.12342. View

Alizadeh Tabari Z, Ghaedi F, Azadmehr A, Nohekhan A, Alizadeh Tabrizi M, Talebi Ardakani M . Salivary Visfatin Concentration in Response to Non-surgical Periodontal Therapy. J Clin Diagn Res. 2015; 9(4):ZC05-8. PMC: 4437149. DOI: 10.7860/JCDR/2015/11537.5773. View

Ziaei N, Golmohammadi S, Ataee M, Ardalani F, Mesgari Abbasi M . Effect of non-surgical periodontal treatment on three salivary adipokines in diabetic patients with periodontitis. J Dent Res Dent Clin Dent Prospects. 2021; 14(3):199-205. PMC: 7770404. DOI: 10.34172/joddd.2020.029. View

Alizadeh Tabari Z, Keshani F, Sharbatdaran M, Banishahabadi A, Nejatifard M, Ghorbani H . Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis. Dent Res J (Isfahan). 2018; 15(2):104-110. PMC: 5858068. View

Ryan M . Nonsurgical approaches for the treatment of periodontal diseases. Dent Clin North Am. 2005; 49(3):611-36, vii. DOI: 10.1016/j.cden.2005.03.010. View

Ognjanovic S, Bao S, Yamamoto S, Samal B, Bryant-Greenwood G . Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol. 2001; 26(2):107-17. DOI: 10.1677/jme.0.0260107. View

10.

Ozcan E, Saygun N, Serdar M, Kurt N . Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation. Clin Oral Investig. 2014; 19(4):921-8. DOI: 10.1007/s00784-014-1308-0. View

11.

Nikolopoulos G, Dimou N, Hamodrakas S, Bagos P . Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol. 2008; 35(9):754-67. DOI: 10.1111/j.1600-051X.2008.01298.x. View

12.

Bayani M, Heidari M, Almasi-Hashiani A . Periodontal disease and visfatin level: A systematic review and meta-analysis. PLoS One. 2023; 18(11):e0293368. PMC: 10629655. DOI: 10.1371/journal.pone.0293368. View

13.

Pradeep A, Raghavendra N, Prasad M, Kathariya R, Patel S, Sharma A . Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. J Periodontol. 2011; 82(9):1314-9. DOI: 10.1902/jop.2011.100690. View

14.

Cetiner D, Uraz A, Oztoprak S, Akca G . The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease. J Appl Oral Sci. 2019; 27:e20180365. PMC: 6690727. DOI: 10.1590/1678-7757-2018-0365. View

15.

Mishra V, Shettar L, Bajaj M, Math A, Thakur S . Interlinking Periodontitis and Type 2 Diabetes Mellitus by Assessment of Crevicular Visfatin Levels in Health and in Disease Before and After Initial Periodontal Therapy. J Clin Diagn Res. 2016; 10(8):ZC67-71. PMC: 5028447. DOI: 10.7860/JCDR/2016/18656.8283. View

16.

Xiao K, Chen L, Mao Y, Bao H, Chen W, Li X . Expression of visfatin in gingival crevicular fluid and gingival tissues in different periodontal conditions: a cross-sectional study. BMC Oral Health. 2024; 24(1):514. PMC: 11064311. DOI: 10.1186/s12903-024-04299-2. View

17.

Ghaemmaghami R, Bayani M, Nakhostin A, Vahid F . A pro-inflammatory diet is associated with an increased odds of periodontitis: finding from a case-control study. BMC Nutr. 2023; 9(1):109. PMC: 10537435. DOI: 10.1186/s40795-023-00760-7. View

18.

Martinez-Garcia M, Hernandez-Lemus E . Periodontal Inflammation and Systemic Diseases: An Overview. Front Physiol. 2021; 12:709438. PMC: 8578868. DOI: 10.3389/fphys.2021.709438. View

19.

Bengi V, Ozcan E, Saygun N, Guler O, Serdar M . Effect of non-surgical periodontal treatment on visfatin and chemerin concentration in the gingival crevicular fluid. Odontology. 2023; 112(1):200-207. DOI: 10.1007/s10266-023-00808-x. View

20.

Raghavendra N, Pradeep A, Kathariya R, Sharma A, Rao N, B Naik S . Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease. Dis Markers. 2012; 32(6):383-8. PMC: 3826798. DOI: 10.3233/DMA-2012-0897. View